Debra Ritzwoller to Cohort Studies
This is a "connection" page, showing publications Debra Ritzwoller has written about Cohort Studies.
Connection Strength
0.631
-
Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose Computed Tomography Screening. J Thorac Oncol. 2022 12; 17(12):1355-1364.
Score: 0.132
-
Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems. JAMA Netw Open. 2021 10 01; 4(10):e2128176.
Score: 0.123
-
Survival after recurrence of stage I-III breast, colorectal, or lung cancer. Cancer Epidemiol. 2017 08; 49:186-194.
Score: 0.092
-
Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer. J Oncol Pract. 2015 Sep; 11(5):356-62.
Score: 0.080
-
Validation of electronic data on chemotherapy and hormone therapy use in HMOs. Med Care. 2013 Oct; 51(10):e67-73.
Score: 0.071
-
Changes in use of opioid therapy after colon cancer diagnosis: a population-based study. Cancer Causes Control. 2019 Dec; 30(12):1341-1350.
Score: 0.027
-
Risk of colon cancer recurrence in relation to diabetes. Cancer Causes Control. 2018 Nov; 29(11):1093-1103.
Score: 0.025
-
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality. Urology. 2018 Sep; 119:70-78.
Score: 0.025
-
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
Score: 0.022
-
Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2014 Oct; 52(10):e65-73.
Score: 0.019
-
Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012 Nov 15; 118(22):5644-51.
Score: 0.016